Product information

Serevent Evohaler 25 µg/dose
120 doses
salmeterol
2396109
8.41 / 10
Locked

Product properties

89365-50-4
R03AC12
GlaxoSmithKline Pharmaceuticals
Pressurised inhalation, suspension
€18.53
BE289177
05400571001195
M1
Public
289177-01

Pharmacist Assessment

Normally available

This product has good current availability (score 8.41/10) and is historically stable (score 🔒/10). No action required.

Note: commercialization of this product will be stopped on 01/01/2027.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 18 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 01/01/2027

Commercial reasons

Under evaluation
Available Active
Until 31/12/2026

Composition

1 ingredient

Substance Type Strength CAS
Active ingredient
36.3 ug/{dose}
94749-08-3

Additional information

Availability statistics

Available
0 days
3
0